Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms (DALIAH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01387763
Recruitment Status : Active, not recruiting
First Posted : July 6, 2011
Last Update Posted : September 3, 2018
Sponsor:
Information provided by (Responsible Party):
Thomas Stauffer Larsen, Odense University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : January 2020
  Estimated Study Completion Date : January 2020